Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro
- PMID: 1645358
- DOI: 10.1002/jcp.1041470120
Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro
Abstract
It has been reported that thrombomodulin (TM) expression in endothelial cells is modulated by various agents. We investigated cellular regulatory mechanisms for TM expression in human umbilical vein endothelial cells (HUVECs), incubated with agents, by measuring the time course changes in surface TM activity, total TM antigen in cell lysates, and TM mRNA levels. While dibutyryl cAMP (3 mM) increased TM mRNA levels in HUVECs and was followed by increased TM activity, dibutyryl cGMP had no effect on TM activity. Phorbol myristate acetate (PMA) induced rapid loss of surface TM activity (approximately 8 h) and later increased TM mRNA levels between 4 h and 40 h (maximum at 24 h), resulting in biphasic effects on TM activity. Tumor necrosis factor or interleukin-1 beta suppressed surface TM activity and TM mRNA levels. Internalization/degradation of TM in HUVECs incubated with PMA or cytokines was suggested by co-culture with chloroquine. The decrease in surface TM activity observed was not caused by the release of TM molecules from the cells into the conditioned media. These results suggest that TM activity in HUVECs is modulated by independent mechanisms involving cytoplasmic TM mRNA levels and internalization/degradation of TM molecules. These regulatory mechanisms may involve protein kinase A and protein kinase C-dependent mechanisms but are independent of protein kinase G.
Similar articles
-
Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells.Thromb Haemost. 1995 May;73(5):812-8. Thromb Haemost. 1995. PMID: 7482408
-
Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro.J Biochem. 1990 Nov;108(5):839-45. doi: 10.1093/oxfordjournals.jbchem.a123290. J Biochem. 1990. PMID: 1964458
-
The biosynthesis of thrombomodulin and its enhancement by dibutyryl cAMP in a human megakaryoblastic cell line, UT-7.Int J Hematol. 1991 Aug;54(4):341-9. Int J Hematol. 1991. PMID: 1663800
-
Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor.Exp Cell Res. 1998 Jan 10;238(1):294-8. doi: 10.1006/excr.1997.3812. Exp Cell Res. 1998. PMID: 9457083
-
[Therapeutic evaluation of recombinant thrombomodulin].Nihon Rinsho. 1992 Oct;50(10):2561-7. Nihon Rinsho. 1992. PMID: 1333021 Review. Japanese.
Cited by
-
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.Immunology. 1996 Jan;87(1):134-40. Immunology. 1996. PMID: 8666425 Free PMC article. Clinical Trial.
-
Thrombomodulin and multiorgan failure in sickle cell anemia.Am J Hematol. 2022 Mar 1;97(3):E102-E105. doi: 10.1002/ajh.26443. Epub 2021 Dec 28. Am J Hematol. 2022. PMID: 34929051 Free PMC article. No abstract available.
-
The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.J Exp Med. 2002 Sep 2;196(5):565-77. doi: 10.1084/jem.20020077. J Exp Med. 2002. PMID: 12208873 Free PMC article.
-
Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.Surg Today. 1995;25(7):585-90. doi: 10.1007/BF00311430. Surg Today. 1995. PMID: 7549268
-
Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals.Immunology. 2002 Nov;107(3):340-9. doi: 10.1046/j.1365-2567.2002.01469.x. Immunology. 2002. PMID: 12423310 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources